A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu

(MedPage Today) -- An interim analysis of the DREAMM-8 trial showed belantamab mafodotin (Blenrep) improved progression-free survival when combined with pomalidomide (Pomalyst) and dexamethasone as second-line treatment for patients with relapsed...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news